|
|
|
Insider
Information: |
Dolsten Mikael |
Relationship: |
Director |
City: |
Madison |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
327,440 |
|
Indirect Shares
|
1,981 |
|
|
Direct
Value |
$10,158,521 |
|
|
Indirect Value
|
$57,390 |
|
|
Total
Shares |
329,421 |
|
|
Total
Value |
$10,215,911 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pfizer Inc |
PFE |
President R&D |
2024-02-28 |
321,729 |
2024-02-28 |
1,981 |
Premium* |
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
5,711 |
2021-09-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PFE |
Pfizer Inc |
Senior Vice President |
|
2009-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
99,824 |
99,824 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
36,212 |
137,987 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2011-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
68,290 |
212,298 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2012-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
42,413 |
263,633 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
96,679 |
368,068 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
64,581 |
380,237 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
28,915 |
380,360 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
23,006 |
525,313 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2016-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
18,530 |
444,759 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
31,800 |
172,115 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
96,183 |
406,261 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
45,566 |
345,753 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2021-09-22 |
4 |
A |
$172.44 |
$97,773 |
D/D |
567 |
567 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2022-03-17 |
4 |
A |
$136.82 |
$244,224 |
D/D |
1,785 |
2,352 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2023-03-16 |
4 |
A |
$136.82 |
$226,848 |
D/D |
1,658 |
4,018 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2024-03-15 |
4 |
A |
$147.48 |
$247,471 |
D/D |
1,678 |
5,711 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2013-02-28 |
4 |
D |
$27.37 |
$891,304 |
D/D |
(32,565) |
335,503 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2014-02-26 |
4 |
D |
$31.99 |
$921,056 |
D/D |
(28,792) |
351,445 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2015-02-25 |
4 |
D |
$33.47 |
$3,782,211 |
D/D |
(111,104) |
414,209 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2016-02-24 |
4 |
D |
$29.67 |
$4,518,495 |
D/D |
(151,673) |
426,229 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2016-02-28 |
4 |
D |
$30.23 |
$288,666 |
D/D |
(9,549) |
435,210 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2017-02-23 |
4 |
D |
$32.49 |
$5,269,931 |
D/D |
(159,600) |
140,315 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2017-02-27 |
4 |
D |
$34.28 |
$1,130,589 |
D/D |
(32,981) |
132,479 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2018-02-24 |
4 |
D |
$35.98 |
$3,954,664 |
D/D |
(109,493) |
115,772 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2018-02-28 |
4 |
D |
$35.70 |
$5,681,080 |
D/D |
(158,482) |
134,870 |
0 |
- |
|
61 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|